Showing 20,621 - 20,640 results of 44,127 for search '(( 5 ((mean decrease) OR (nn decrease)) ) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 20621
  2. 20622
  3. 20623

    DataSheet1_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.docx by Zehua Zhang (312656)

    Published 2022
    “…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”
  4. 20624

    Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials by Francesco Giorgino (385654)

    Published 2025
    “…The incidence of GI AEs (generally mild-to-moderate events) decreased over time and was, in general, comparable between early and non-early responders. …”
  5. 20625

    Bone Mineral Density Changes among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis with Tenofovir-Emtricitabine or Placebo in Botswana by Michael Kasonde (534785)

    Published 2014
    “…</p><p>Conclusion</p><p>Use of TDF-FTC was associated with a small but statistically significant decrease in BMD at the forearm, hip and lumbar spine. …”
  6. 20626

    Image1_Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats.JPEG by Hsien-Yu Peng (10877709)

    Published 2021
    “…Though administering to naïve animals solifenacin, but not mirabegron (both 1 × 10<sup>−5</sup>−1 × 10<sup>−1</sup> mg/kg, i.a.) decreased the peak pressure, both of these reagents exhibited acute increments in the trajectory slope and Cm of the filling phase in a dose-dependent manner (ED<sub>50</sub> = 1.4 × 10<sup>−4</sup> and 2.2 × 10<sup>−5</sup> mg/kg, respectively). …”
  7. 20627

    Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor by Thérèse Keravis (188522)

    Published 2012
    “…NCS 613 is a potent inhibitor, which is more selective for the PDE4C subtype (IC<sub>50</sub> = 1.4 nM) than the other subtypes (PDE4A, IC<sub>50</sub> = 44 nM; PDE4B, IC<sub>50</sub> = 48 nM; and PDE4D, IC<sub>50</sub> = 14 nM). …”
  8. 20628

    Table1_Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility.DOCX by Serena Correnti (17051112)

    Published 2023
    “…<p>Male infertility occurs approximately in about 50% of all infertility cases and represents a serious concern worldwide. …”
  9. 20629

    Image_1_Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020.jpeg... by Zoltán Kiss (5570003)

    Published 2023
    “…Age-standardized incidence rates varied between 116.73 and 106.16/100,000 PYs, showing a mean annual change of -0.7% (95% CI: -1.21%–0.16%) and a total change of -5.41% (95% CI: -9.24 to -1.32). …”
  10. 20630

    table2_Beneficial Potential of Banha-Sasim-Tang for Stress-Sensitive Functional Dyspepsia via Modulation of Ghrelin: A Randomized Controlled Trial.docx by Sul-Ki Kim (10671891)

    Published 2021
    “…</p><p>Results: All participants completed the study (n = 15 for BST, n = 16 for placebo). BST decreased NDI-K scores compared with placebo, but the difference was not statistically significant (37.40 ± 27.40 vs 22.50 ± 23.85, p = 0.12). …”
  11. 20631

    table5_Beneficial Potential of Banha-Sasim-Tang for Stress-Sensitive Functional Dyspepsia via Modulation of Ghrelin: A Randomized Controlled Trial.doc by Sul-Ki Kim (10671891)

    Published 2021
    “…</p><p>Results: All participants completed the study (n = 15 for BST, n = 16 for placebo). BST decreased NDI-K scores compared with placebo, but the difference was not statistically significant (37.40 ± 27.40 vs 22.50 ± 23.85, p = 0.12). …”
  12. 20632

    table3_Beneficial Potential of Banha-Sasim-Tang for Stress-Sensitive Functional Dyspepsia via Modulation of Ghrelin: A Randomized Controlled Trial.docx by Sul-Ki Kim (10671891)

    Published 2021
    “…</p><p>Results: All participants completed the study (n = 15 for BST, n = 16 for placebo). BST decreased NDI-K scores compared with placebo, but the difference was not statistically significant (37.40 ± 27.40 vs 22.50 ± 23.85, p = 0.12). …”
  13. 20633

    table1_Beneficial Potential of Banha-Sasim-Tang for Stress-Sensitive Functional Dyspepsia via Modulation of Ghrelin: A Randomized Controlled Trial.docx by Sul-Ki Kim (10671891)

    Published 2021
    “…</p><p>Results: All participants completed the study (n = 15 for BST, n = 16 for placebo). BST decreased NDI-K scores compared with placebo, but the difference was not statistically significant (37.40 ± 27.40 vs 22.50 ± 23.85, p = 0.12). …”
  14. 20634

    table4_Beneficial Potential of Banha-Sasim-Tang for Stress-Sensitive Functional Dyspepsia via Modulation of Ghrelin: A Randomized Controlled Trial.docx by Sul-Ki Kim (10671891)

    Published 2021
    “…</p><p>Results: All participants completed the study (n = 15 for BST, n = 16 for placebo). BST decreased NDI-K scores compared with placebo, but the difference was not statistically significant (37.40 ± 27.40 vs 22.50 ± 23.85, p = 0.12). …”
  15. 20635
  16. 20636

    Table1_Ocean warming enhances the competitive advantage of Ulva prolifera over a golden tide alga, Sargassum horneri under eutrophication.docx by Hailong Wu (84632)

    Published 2024
    “…In monocultures, the growth of U. prolifera and S. horneri, along with pigment concentrations and photosynthesis, increased with rising temperature, reaching a plateau at 15 - 25°C. However, when the temperature increased to 30°C, the growth of U. prolifera and S. horneri decreased abruptly, with S. horneri even suffering death. …”
  17. 20637

    Supplementary Material for: An early phase 2 double-blind, placebo-controlled study of E6011, a novel anti-fractalkine antibody, in patients with Crohn’s disease by figshare admin karger (2628495)

    Published 2025
    “…The primary efficacy endpoint was the percentage of patients who achieved a decrease in the CD activity index (CDAI) by ≥ 100 points from baseline at Week 12. …”
  18. 20638

    Data_Sheet_1_Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model.PDF by David Chauvin (6504965)

    Published 2019
    “…Among them, invasive pulmonary aspergillosis has become a major concern as mortality rates exceed 50% in immunocompromised hosts. …”
  19. 20639

    Immunofluorescence analysis of lumbar spinal cord sections at 3 months after spinal cord transection. by Jose A. Corleto (841164)

    Published 2016
    “…<b>(G, H, I)</b>- Quantitative densitometric analysis of GAD65, GFAP and IB1 immunoreactivity showed a decrease in GAD65 and increase in GFAP and IB1 staining in TSCT animals if compared to naïve controls (t-test ***-p<0.001; scale bar: A, B: 50 μm C, D, E, F: 200 μm).…”
  20. 20640

    DataSheet_1_Efficacy and safety of herbal formulas with the function of gut microbiota regulation for gastric and colorectal cancer: A systematic review and meta-analysis.docx by Bowen Xu (5903801)

    Published 2022
    “…There were no significant differences in ORR [RR = 1.32, 95% CI (0.94~1.86)] and DCR [RR = 1.22, 95% CI (0.99~1.50)], but they can improve the KPS response rate [RR = 1.62, 95% CI (1.13, 2.32)] and decrease the incidence of myelosuppression, nausea and vomiting, diarrhea, and hepatic and renal dysfunction in CRC.…”